These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32566694)

  • 1. Overall survival prediction in glioblastoma patients using structural magnetic resonance imaging (MRI): advanced radiomic features may compensate for lack of advanced MRI modalities.
    Bakas S; Shukla G; Akbari H; Erus G; Sotiras A; Rathore S; Sako C; Min Ha S; Rozycki M; Shinohara RT; Bilello M; Davatzikos C
    J Med Imaging (Bellingham); 2020 May; 7(3):031505. PubMed ID: 32566694
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrative radiomic analysis for pre-surgical prognostic stratification of glioblastoma patients: from advanced to basic MRI protocols.
    Bakas S; Shukla G; Akbari H; Erus G; Sotiras A; Rathore S; Sako C; Min Ha S; Rozycki M; Singh A; Shinohara R; Bilello M; Davatzikos C
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11315():. PubMed ID: 33746333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
    Kickingereder P; Burth S; Wick A; Götz M; Eidel O; Schlemmer HP; Maier-Hein KH; Wick W; Bendszus M; Radbruch A; Bonekamp D
    Radiology; 2016 Sep; 280(3):880-9. PubMed ID: 27326665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma.
    Kickingereder P; Neuberger U; Bonekamp D; Piechotta PL; Götz M; Wick A; Sill M; Kratz A; Shinohara RT; Jones DTW; Radbruch A; Muschelli J; Unterberg A; Debus J; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Maier-Hein KH; Bendszus M
    Neuro Oncol; 2018 May; 20(6):848-857. PubMed ID: 29036412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
    Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
    Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Glioma Grade Using Intratumoral and Peritumoral Radiomic Features From Multiparametric MRI Images.
    Cheng J; Liu J; Yue H; Bai H; Pan Y; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):1084-1095. PubMed ID: 33104503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent Diffusion Coefficient as a Predictive Biomarker for Survival in Patients with Treatment-Naive Glioblastoma Using Quantitative Multiparametric Magnetic Resonance Profiling.
    Kim BS; Kim ST; Kim JH; Seol HJ; Nam DH; Shin HJ; Lee JI; Kong DS
    World Neurosurg; 2019 Feb; 122():e812-e820. PubMed ID: 30391622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
    Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
    Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics prognostication model in glioblastoma using diffusion- and perfusion-weighted MRI.
    Park JE; Kim HS; Jo Y; Yoo RE; Choi SH; Nam SJ; Kim JH
    Sci Rep; 2020 Mar; 10(1):4250. PubMed ID: 32144360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between pilocytic astrocytoma and glioblastoma: a decision tree model using contrast-enhanced magnetic resonance imaging-derived quantitative radiomic features.
    Dong F; Li Q; Xu D; Xiu W; Zeng Q; Zhu X; Xu F; Jiang B; Zhang M
    Eur Radiol; 2019 Aug; 29(8):3968-3975. PubMed ID: 30421019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multi-parametric MRI-Based Radiomics Signature and a Practical ML Model for Stratifying Glioblastoma Patients Based on Survival Toward Precision Oncology.
    Osman AFI
    Front Comput Neurosci; 2019; 13():58. PubMed ID: 31507398
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
    Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
    Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction.
    Bae S; Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Radiology; 2018 Dec; 289(3):797-806. PubMed ID: 30277442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of image preprocessing on the scanner dependence of multi-parametric MRI radiomic features and covariate shift in multi-institutional glioblastoma datasets.
    Um H; Tixier F; Bermudez D; Deasy JO; Young RJ; Veeraraghavan H
    Phys Med Biol; 2019 Aug; 64(16):165011. PubMed ID: 31272093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness.
    Damascelli A; Gallivanone F; Cristel G; Cava C; Interlenghi M; Esposito A; Brembilla G; Briganti A; Montorsi F; Castiglioni I; De Cobelli F
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33810222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
    J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.